Kyoto, Japan

Kouji Mizuno


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2002-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kouji Mizuno: Innovator in Biochemical Research

Introduction

Kouji Mizuno is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of biochemical research, particularly in the area of lysophosphatidic acid phosphatase. With a total of 2 patents, his work has implications for both diagnosis and treatment of various diseases.

Latest Patents

Mizuno's latest patents focus on recombinant lysophosphatidic acid phosphatase. The primary objective of this invention is to provide a recombinant LPA phosphatase capable of specifically hydrolyzing LPA. This capability is crucial for elucidating the metabolic pathway of LPA and for diagnosing and treating diseases associated with it. The invention includes methods for determining LPA levels in a simple and cost-effective manner, as well as a kit designed for this purpose. The successful purification of LPA phosphatase using bovine brain as raw material and the cloning of the human LPA phosphatase gene are notable achievements in this patent.

Career Highlights

Kouji Mizuno is currently associated with Azwell Inc., where he continues to advance his research in biochemistry. His work has garnered attention for its potential applications in medical diagnostics and therapeutic interventions.

Collaborations

Mizuno has collaborated with notable colleagues such as Tadaomi Takenawa and Masami Hiroyama. Their combined expertise has contributed to the success of their research endeavors.

Conclusion

Kouji Mizuno's innovative work in the field of biochemical research highlights the importance of lysophosphatidic acid phosphatase in medical science. His contributions pave the way for advancements in diagnosis and treatment of diseases, showcasing the impact of dedicated research and collaboration.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…